Research and Markets: Breast Cancer Therapeutics Pipeline Review, H1 2015 - Features 346 Companies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/hl4dpc/breast_cancer) has announced the addition of the "Breast Cancer - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Breast Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Breast Cancer Overview
  3. Therapeutics Development
  4. Breast Cancer - Therapeutics under Development by Companies
  5. Breast Cancer - Therapeutics under Investigation by Universities/Institutes
  6. Breast Cancer - Pipeline Products Glance
  7. Breast Cancer - Products under Development by Companies
  8. Breast Cancer - Products under Investigation by Universities/Institutes
  9. Breast Cancer - Companies Involved in Therapeutics Development
  10. Breast Cancer - Therapeutics Assessment
  11. Drug Profiles
  12. Breast Cancer - Recent Pipeline Updates
  13. Breast Cancer - Dormant Projects
  14. Breast Cancer - Discontinued Products
  15. Breast Cancer - Product Development Milestones
  16. Appendix

Companies Mentioned: 1st 30 Companies

  • 3-V Biosciences, Inc.
  • A&G Pharmaceutical, Inc.
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • AB Science
  • AbbVie Inc.
  • AbGenomics International, Inc.
  • Actinium Pharmaceuticals, Inc.
  • Adaptimmune Limited
  • Advanced Cancer Therapeutics
  • Advanced Proteome Therapeutics Corporation
  • Advaxis, Inc.
  • Advenchen Laboratories, LLC
  • Aegis Therapeutics, LLC
  • Aerpio Therapeutics, Inc.
  • Aeterna Zentaris Inc.
  • Affichem
  • Aileron Therapeutics, Inc.
  • Alchemia Limited
  • Alethia Biotherapeutics Inc.
  • Almac Discovery Ltd.
  • AlphaMab Co., Ltd
  • AlphaVax, Inc.
  • Amarna Therapeutics B.V.
  • Ambrx, Inc.
  • Amgen Inc.
  • Ampio Pharmaceuticals, Inc.
  • Amplyx Pharmaceuticals, Inc.
  • AngioGenex, Inc.
  • Angion Biomedica Corp.
  • AntiCancer, Inc.

For more information visit http://www.researchandmarkets.com/research/hl4dpc/breast_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology